Published in J Clin Invest on November 01, 1996
Pivotal role of the renin/prorenin receptor in angiotensin II production and cellular responses to renin. J Clin Invest (2002) 6.27
Inhibition of diabetic nephropathy by a decoy peptide corresponding to the "handle" region for nonproteolytic activation of prorenin. J Clin Invest (2004) 2.24
Combination therapy with AT1 blocker and vitamin D analog markedly ameliorates diabetic nephropathy: blockade of compensatory renin increase. Proc Natl Acad Sci U S A (2008) 2.06
The world pandemic of vitamin D deficiency could possibly be explained by cellular inflammatory response activity induced by the renin-angiotensin system. Am J Physiol Cell Physiol (2013) 1.56
Vitamin D deficiency and persistent proteinuria among HIV-infected and uninfected injection drug users. AIDS (2012) 1.41
New insights and perspectives on intrarenal renin-angiotensin system: focus on intracrine/intracellular angiotensin II. Peptides (2011) 1.32
A current view of brain renin-angiotensin system: Is the (pro)renin receptor the missing link? Pharmacol Ther (2009) 1.19
A genetically clamped renin transgene for the induction of hypertension. Proc Natl Acad Sci U S A (2002) 1.15
Therapeutic effects of vitamin D analogs on cardiac hypertrophy in spontaneously hypertensive rats. Am J Pathol (2010) 1.09
The Prorenin and (Pro)renin Receptor: New Players in the Brain Renin-Angiotensin System? Int J Hypertens (2012) 0.98
Receptor-dependent prorenin activation and induction of PAI-1 expression in vascular smooth muscle cells. Am J Physiol Endocrinol Metab (2008) 0.93
The (pro)renin receptor. A decade of research: what have we learned? Pflugers Arch (2012) 0.81
Cardiorenal syndrome is present in human fetuses with severe, isolated urinary tract malformations. PLoS One (2013) 0.81
Role of aliskiren in cardio-renal protection and use in hypertensives with multiple risk factors. Ther Clin Risk Manag (2009) 0.78
Prorenin anno 2008. J Mol Med (Berl) (2008) 0.78
Update on RAAS Modulation for the Treatment of Diabetic Cardiovascular Disease. J Diabetes Res (2016) 0.78
Increased dietary NaCl potentiates the effects of elevated prorenin levels on blood pressure and organ disease. J Hypertens (2010) 0.75
Effect of Proteinuria and Glomerular Filtration Rate on Renal Outcome in Patients with Biopsy-Proven Benign Nephrosclerosis. PLoS One (2016) 0.75
Higher plasma prorenin concentration plays a role in the development of coronary artery disease. Biomark Res (2015) 0.75
Renin inhibitors in diabetes and hypertension: an update. EXCLI J (2014) 0.75
A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem (1976) 903.81
Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem (1987) 281.19
A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. Anal Biochem (1983) 206.01
Molecular basis of human hypertension: role of angiotensinogen. Cell (1992) 6.07
Essential hypertension: renin and aldosterone, heart attack and stroke. N Engl J Med (1972) 4.80
Association of the renin-sodium profile with the risk of myocardial infarction in patients with hypertension. N Engl J Med (1991) 3.86
Fulminant hypertension in transgenic rats harbouring the mouse Ren-2 gene. Nature (1990) 2.54
Measurement of renin activity, concentration and substrate in rat plasma by radioimmunoassay of angiotensin I. Endocrinology (1972) 2.13
Identification of a second mutation in the protein-coding sequence of the Z type alpha 1-antitrypsin gene. J Biol Chem (1986) 1.60
Tissue specific expression of the human alpha-1-antitrypsin gene in transgenic mice. Nucleic Acids Res (1987) 1.51
Prorenin and other large molecular weight forms of renin. Endocr Rev (1980) 1.33
Plasma prorenin activity and complications in children with insulin-dependent diabetes mellitus. N Engl J Med (1990) 1.27
Increased expression of angiotensin peptides in the brain of transgenic hypertensive rats. Peptides (1994) 1.26
Tumor cells are the site of erythropoietin synthesis in human renal cancers associated with polycythemia. Blood (1990) 1.20
Angiotensin and cell growth: a link to cardiovascular hypertrophy? J Hypertens (1991) 1.11
Human prorenin. Hypertension (1991) 0.97
Identification of vascular renin-binding proteins by chemical cross-linking: inhibition of binding of renin by renin inhibitors. J Hypertens (1994) 0.96
Prorenin and renin as separate mediators of tissue and circulating systems. Am J Hypertens (1989) 0.96
Calcium blockade versus ACE inhibition in clipped and unclipped kidneys of 2K-1C rats. Kidney Int (1994) 0.94
Proteolytic processing of human prorenin in renal and non-renal tissues. Kidney Int (1994) 0.91
The role of mechanical and humoral factors in growth regulation of vascular smooth muscle and cardiac myocytes. Curr Opin Nephrol Hypertens (1993) 0.88
The angiotensin-converting enzyme (ACE) genetic polymorphism: its relationship with plasma ACE level and myocardial infarction. Clin Genet (1994) 0.86
Sequence requirements for prohormone processing in mouse pituitary AtT-20 cells. Analysis using prorenins as model substrates. Eur J Biochem (1991) 0.85
Characterization of recombinant human factor IX expressed in transgenic mice and in derived trans-immortalized hepatic cell lines. EMBO J (1990) 0.85
Half-life, hemodynamic, renal, and hormonal effects of prorenin in cynomolgus monkeys. Am J Physiol (1991) 0.85
A structural model to explain the partial catalytic activity of human prorenin. Am J Hypertens (1989) 0.84
Increased vascular angiotensin formation in female rats harboring the mouse Ren-2 gene. Hypertension (1992) 0.84
Reversible activation-inactivation of renin in human plasma. Nature (1980) 0.84
Developmental studies demonstrate age-dependent elevation of renin activity in TGR(mRen2)27 rats. Am J Hypertens (1995) 0.82
Zonal distribution and regulation of adrenal renin in a transgenic model of hypertension in the rat. Endocrinology (1992) 0.81
Activation and function of prorenin: different viewpoints. Can J Physiol Pharmacol (1991) 0.80
Sexual dimorphism of inactive renin in rat plasma. Clin Exp Hypertens A (1990) 0.80
A novel assay of plasma prorenin using a renin inhibitor. J Hypertens Suppl (1993) 0.79
Is prorenin of physiological and clinical significance? J Hypertens (1988) 0.78
Sp1 sites in the mouse aprt gene promoter are required to prevent methylation of the CpG island. Genes Dev (1994) 4.95
Consistent cytotoxic-T-lymphocyte targeting of immunodominant regions in human immunodeficiency virus across multiple ethnicities. J Virol (2004) 4.12
A scale for the assessment of hedonic tone the Snaith-Hamilton Pleasure Scale. Br J Psychiatry (1995) 3.89
Results at 1 year of outpatient multidisciplinary pulmonary rehabilitation: a randomised controlled trial. Lancet (2000) 3.68
Cloned pigs produced by nuclear transfer from adult somatic cells. Nature (2000) 3.51
Identification of Grf1 on mouse chromosome 9 as an imprinted gene by RLGS-M. Nat Genet (1996) 2.77
Premature discontinuation of clinical trial for reasons not related to efficacy, safety, or feasibility. BMJ (2001) 2.74
Facing others in pain: the effects of empathy. Pain (2005) 2.68
Converting enzyme inhibition and kidney function in normotensive diabetic patients with persistent microalbuminuria. Br Med J (Clin Res Ed) (1987) 2.67
Campylobacter-like organisms and surface epithelium abnormalities in active, chronic gastritis in humans: an ultrastructural study. Ultrastruct Pathol (1986) 2.64
Frequency of patients' consulting in general practice and workload generated by frequent attenders: comparisons between practices. Br J Gen Pract (1998) 2.37
Acute angiotensin-converting enzyme inhibition increases the plasma level of the natural stem cell regulator N-acetyl-seryl-aspartyl-lysyl-proline. J Clin Invest (1996) 2.20
Indoor moulds and asthma. J R Soc Health (1988) 2.19
Sources and incidence of airborne Aspergillus fumigatus (Fres). Clin Allergy (1976) 2.17
Cellular therapy reverses myocardial dysfunction. J Thorac Cardiovasc Surg (2001) 2.16
Asthma admissions and thunderstorms: a study of pollen, fungal spores, rainfall, and ozone. QJM (2001) 2.10
Responses of consecutive patients to reassurance after gastroscopy: results of self administered questionnaire survey. BMJ (1997) 2.07
Protozoa as sources of antigen in 'humidifier fever'. Nature (1976) 2.06
The 1993 guidelines for the management of mild hypertension: memorandum from a WHO/ISH meeting. Blood Press (1993) 2.03
Familial resemblance of plasma angiotensin-converting enzyme level: the Nancy Study. Am J Hum Genet (1988) 1.98
The differentiation of anxiety and depression by rating scales. Acta Psychiatr Scand (1988) 1.95
Rapid loss of Oct-4 and pluripotency in cultured rodent blastocysts and derivative cell lines. Biol Reprod (2003) 1.91
Intravenous safety and pharmacokinetics of a novel dimerizer drug, AP1903, in healthy volunteers. J Clin Pharmacol (2001) 1.91
Real world data--retrieval and validation of consultation data from four general practices. Fam Pract (1996) 1.88
A comparison of noncontrast computerized tomography with excretory urography in the assessment of acute flank pain. J Urol (1999) 1.85
High plasma level of N-acetyl-seryl-aspartyl-lysyl-proline: a new marker of chronic angiotensin-converting enzyme inhibition. Hypertension (1997) 1.71
Memory for pain: a review. Pain (1990) 1.70
Outcome of subclinical antibody-mediated rejection in kidney transplant recipients with preformed donor-specific antibodies. Am J Transplant (2009) 1.67
Significance of C4d Banff scores in early protocol biopsies of kidney transplant recipients with preformed donor-specific antibodies (DSA). Am J Transplant (2011) 1.66
Home self blood pressure measurement in general practice. The SMART study. Self-measurement for the Assessment of the Response to Trandolapril. Am J Hypertens (1996) 1.66
Early glomerular macrophage recruitment in streptozotocin-induced diabetic rats. Diabetes (2000) 1.63
Very late heart transplant rejection is associated with microvascular injury, complement deposition and progression to cardiac allograft vasculopathy. Am J Transplant (2011) 1.57
Fungal spores in lung and sputum. Clin Allergy (1978) 1.55
Cognitive-processing bias in chronic pain: a review and integration. Psychol Bull (2001) 1.49
Peritubular cells are the site of erythropoietin synthesis in the murine hypoxic kidney. J Clin Invest (1988) 1.48
[Characteristics of smokers seeking smoking cessation services: the CDT programme]. Rev Mal Respir (2005) 1.47
Targeting of a CD8 T cell env epitope presented by HLA-B*5802 is associated with markers of HIV disease progression and lack of selection pressure. AIDS Res Hum Retroviruses (2008) 1.46
Cholesterol crystal embolization demonstrated on GI biopsy. Am J Gastroenterol (2001) 1.46
Memory for acute pain experience is specifically inaccurate but generally reliable. Pain (1993) 1.46
Respective role of humoral factors and blood pressure in aortic remodeling of DOCA hypertensive rats. Am J Hypertens (1996) 1.44
Antiphospholipid antibodies and atherosclerosis. Am J Med (1992) 1.41
Additive effects of combined angiotensin-converting enzyme inhibition and angiotensin II antagonism on blood pressure and renin release in sodium-depleted normotensives. Circulation (1995) 1.38
Aminoguanidine prevents age-related arterial stiffening and cardiac hypertrophy. Proc Natl Acad Sci U S A (1998) 1.36
Genetically increased angiotensin I-converting enzyme level and renal complications in the diabetic mouse. Proc Natl Acad Sci U S A (2001) 1.34
Serum amyloid A: production by human white adipocyte and regulation by obesity and nutrition. Diabetologia (2005) 1.33
Mild hypertension: the mysterious viability of a faulty concept. J Hypertens (1995) 1.31
Psychological therapies for the management of chronic and recurrent pain in children and adolescents. Cochrane Database Syst Rev (2003) 1.30
Regional variations in grass pollen seasons in the UK, long-term trends and forecast models. Clin Exp Allergy (1999) 1.28
Reproducibility of the 6-minute walk test in obese adults. Int J Sports Med (2009) 1.28
Recurrence of acoustic neurilemoma as a malignant spindle-cell neoplasm. Case report. J Neurosurg (1990) 1.24
Determinants of angiotensin II generation during converting enzyme inhibition. Hypertension (1990) 1.23
Synergistic effects of ACE inhibition and Ang II antagonism on blood pressure, cardiac weight, and renin in spontaneously hypertensive rats. Circulation (1997) 1.22
[Screening for phaeochromocytoma : in which hypertensive patients? A semiological study of 2585 patients, including 11 with phaeochromocytoma (author's transl)]. Nouv Presse Med (1981) 1.22
Tumor cells are the site of erythropoietin synthesis in human renal cancers associated with polycythemia. Blood (1990) 1.20
Relationships between airborne fungal spore concentration of Cladosporium and the summer climate at two sites in Britain. Int J Biometeorol (2003) 1.20
Skin involvement in scleroderma--where histological and clinical scores meet. Rheumatology (Oxford) (2007) 1.20
Systematic review of outpatient services for chronic pain control. Health Technol Assess (1997) 1.19
Medical reassurance and patients' responses. J Psychosom Res (1998) 1.18
Faecal lactoferrin--a novel test to differentiate between the irritable and inflamed bowel? Aliment Pharmacol Ther (2010) 1.18
Dietary sources and correlates of sodium and potassium intakes in the French general population. Eur J Clin Nutr (2009) 1.18
Selective tumor uptake of a boronated porphyrin in an animal model of cerebral glioma. Proc Natl Acad Sci U S A (1992) 1.17
Angiotensinogen: an attractive and underrated participant in hypertension and inflammation. Hypertension (1991) 1.16
Distribution of Salmonella in swine herds in Québec. Vet Microbiol (1999) 1.16
Posttransplantation relapse of FSGS is characterized by glomerular epithelial cell transdifferentiation. J Am Soc Nephrol (2001) 1.15
Angiotensinogen concentrations and renin clearance : implications for blood pressure regulation. Hypertension (2000) 1.12
Angiotensin I converting enzyme in human intestine and kidney. Ultrastructural immunohistochemical localization. Histochemistry (1986) 1.12
Cardiovascular abnormalities with normal blood pressure in tissue kallikrein-deficient mice. Proc Natl Acad Sci U S A (2001) 1.11
Expression of individual lamins in basal cell carcinomas of the skin. Br J Cancer (2001) 1.11
Myelin oligodendrocyte glycoprotein induces a demyelinating encephalomyelitis resembling multiple sclerosis. J Immunol (1995) 1.10
Correlation between clinical and histologic patterns of degenerative mitral valve insufficiency: a histomorphometric study of 130 excised segments. Cardiovasc Pathol (2000) 1.10
Is exocrine pancreatic insufficiency in adult coeliac disease a cause of persisting symptoms? Aliment Pharmacol Ther (2007) 1.10
Functional and morphological modifications of the urinary bladder in aging female rats. Am J Physiol Regul Integr Comp Physiol (2000) 1.09
Atheroembolism in HIV-positive individuals. Lancet (1992) 1.09
Cell-free arterial grafts: morphologic characteristics of aortic isografts, allografts, and xenografts in rats. J Vasc Surg (1994) 1.08
Gene regulation of the serine proteinase inhibitors alpha1-antitrypsin and alpha1-antichymotrypsin. Biochem Soc Trans (2002) 1.08
The role of the adrenal gland in hypertensive transgenic rat TGR(mREN2)27. Endocrinology (1992) 1.08
A micromethod for measurement of renin in the plasma and kidney of rats. Can J Physiol Pharmacol (1967) 1.07
Plasma level and gene polymorphism of angiotensin-converting enzyme in relation to myocardial infarction. Circulation (1994) 1.07
Pharmacological postconditioning with the phytoestrogen genistein. J Mol Cell Cardiol (2006) 1.07
The neurohypophyseal hormones vasopressin and oxytocin. Precursor structure, synthesis and regulation. Biol Chem Hoppe Seyler (1986) 1.06
Cardiac weight in hypertension induced by nitric oxide synthase blockade. Hypertension (1993) 1.05
Hypothenar hammer syndrome: seventeen cases with long-term follow-up. J Vasc Surg (1987) 1.04
Glomerular matrix proteins in nodular glomerulosclerosis in association with light chain deposition disease and diabetes mellitus. Hum Pathol (1985) 1.04
The alpha-tocopherol transfer protein. Vitam Horm (2007) 1.03
Transgenic rats carrying the mouse renin gene--morphological characterization of a low-renin hypertension model. Kidney Int (1992) 1.03
Identification of tissues and cells producing erythropoietin in the anemic mouse. Contrib Nephrol (1988) 1.03
The international database of self-recorded blood pressures in normotensive and untreated hypertensive subjects. Blood Press Monit (1999) 1.03
Expression of MAGE and GAGE in high-grade brain tumors: a potential target for specific immunotherapy and diagnostic markers. Clin Cancer Res (1999) 1.03
Expression and mutational status of treatment-relevant targets and key oncogenes in 123 malignant salivary gland tumours. Ann Oncol (2013) 1.03
'I always seem to be there'--a qualitative study of frequent attenders. Br J Gen Pract (2000) 1.02
Assessment of immune response to meningococcal disease: comparison of a whole-blood assay and the serum bactericidal assay. Microb Pathog (1999) 1.02
Membranous glomerulonephritis and Landry-Guillain-Barre syndrome. Am J Kidney Dis (1986) 1.01
High human renin hypertension in transgenic rats. Hypertension (1997) 1.00
Immunolocalization of the Na+/H+ exchanger isoform NHE2 in rat kidney. Am J Physiol (1998) 1.00
Expression of the familial cardiac valvular dystrophy gene, filamin-A, during heart morphogenesis. Dev Dyn (2010) 1.00
Gene trap integrations expressed in the developing heart: insertion site affects splicing of the PT1-ATG vector. Dev Dyn (1998) 0.99
[Epithelioid hemangioendothelioma of the azygos vein]. Arch Mal Coeur Vaiss (1989) 0.99
Computer-assisted techniques for evaluation and treatment of hypertensive patients. Am J Hypertens (1990) 0.99